← All diseases
Cancer
Ovarian cancer
Do you want to receive a message when there is new research about Ovarian cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication there is one sentence explaining what was investigated — and you will receive a message as soon as there is new research about Ovarian cancer. View what Premium costs.
Publications and studies (2862)
- Transcriptome-wide association studies implicate RCC1 and PHACTR4 in prostate cancer survival. (2026/08/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy. (2026/08/01) ♡
- Effect of neoadjuvant chemotherapy on [(68)Ga]Ga-FAPI-46 PET/CT in peritoneal carcinomatosis: a prospective translational exploratory sub-cohort analysis. (2026/08/01) ♡
- HDAC2-Mediated SMAD7 Stabilisation Activates Wnt/β-Catenin Signalling to Drive DNA Damage Repair and Cisplatin Resistance in Ovarian Cancer. (2026/08/01) ♡
- Recombinant Antifreeze Protein Type I as a Potential Peptide-Based Anti-Fouling Material for Biomedical Surfaces. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Preoperative Hyperglycemia in GYN Surgery: Perioperative Considerations. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current Advances of Molecular Biomarkers and Liquid Biopsies Techniques in Ovarian Cancer. (2026/08/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pelvic Wandering Spleen Mimicking an Ovarian Germ Cell Tumor. (2026/08/01) ♡
- Synergistic action of Yinyanghuo A and Magnograndiolide against ovarian cancer: A computational prediction of targets and mechanism via network pharmacology and molecular simulations. (2026/08/01) ♡
- Associations of Age With Tumor Genomic Characteristics in Relapsed/Refractory Cancers Interrogated With the NCI-MATCH Trial Targeted Gene Panel Assay. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Three-dimensional cell cultures as an in vitro tool for ovarian cancer modeling and natural product discovery. (2026/07/31) ♡
- Use of Radiographic Features for Risk Stratification of Ovarian Masses in Children and Adolescents. (2026/07/31) ♡
- Computational identification of natural phytochemicals as potential inhibitors of UBE2J1 causing ovarian cancer. (2026/07/31) ♡
- Automated segmentation of pretreatment computed tomography for evaluating intersite radiomic heterogeneity between platinum-resistant and platinum-sensitive ovarian cancer cohorts: a proof of concept study. (2026/07/31) ♡
- Entero-Articular Fistula Following Total Hip Arthroplasty in a Patient Post Pelvic Exenteration. (2026/07/30) ♡
- The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming. (2026/07/30) ♡
- Ovarian Cancer Mortality Trend in Montenegro, 1990-2018. (2026/07/29) ♡
- Risk Factors for Urinary Tract Infection in Gynecological Malignant Tumor Inpatients: A Retrospective Study. (2026/07/29) ♡
- Chemotherapy-driven gut microbiota remodeling in ovarian cancer: a prospective longitudinal study. (2026/07/29) ♡
- BRCA2-deficient endothelium: a hidden catalyst in angiotensin II-induced vascular injury. (2026/07/28) ♡
- One-carbon metabolism nutrients and polygenic risk scores in relation to breast cancer risk: A nested case-control study within the EPIC cohort. (2026/07/28) ♡
- Essentiality-driven prediction of anticancer drug responses in preclinical and clinical contexts. (2026/07/27) ♡
- cfDNA-inferred putative clonal hematopoiesis during first-line platinum-to-PARP inhibitor maintenance in ovarian cancer. (2026/07/27) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Interval debulking with HIPEC in patient with VP shunt. (2026/07/27) ♡
- Treatment-related Cognitive Impairment, Neurovascular Coupling, and Iron Levels in Women with Ovarian Cancer. (2026/07/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. From dual inhibition to precision selectivity: the molecular rationale and clinical evolution of next-generation PARP1-selective inhibitors in solid tumors. (2026/07/24) ♡
- Incidental Detection of Ovarian Hyperstimulation on FDG PET/CT After Oocyte Retrieval in a Breast Cancer Patient. (2026/07/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting the deubiquitinase USP28 in cancer: navigating context-dependent mechanisms and therapeutic resistance. (2026/07/23) ♡
- Integrative phosphoproteomics reveals kinase-mediated regulation of OCIAD1 and its roles in mitochondrial quality control. (2026/07/23) ♡
- Higher carbohydrate quality, but not quantity, is associated with lower lung cancer risk in a population-based prospective cohort study. (2026/07/23) ♡
- DUSP5 contributes to platinum resistance in ovarian cancer: single-cell discovery and functional validation. (2026/07/23) ♡
- Endometrial thickness evaluation with ultrasonography assessment among normal and endometrial cancer across multi-ethnic Indonesian women. (2026/07/23) ♡
- Reconciling modest median progression-free survival and larger overall survival gains in platinum-resistant ovarian cancer. (2026/07/23) ♡
- Systems-Level Mapping of the Tumor Microenvironment Reveals Immune-Mediated Mechanisms and Potential Targets in Platinum-Resistant Ovarian Cancer. (2026/07/22) ♡
- Tasisulam-induced suicidal death of human erythrocytes. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances and challenges in biomarker guided management of triple-negative breast cancer in the era of neoadjuvant chemo-immunotherapy. (2026/07/22) ♡
- Genomic Profile of Interleukin-6 Secreting Ovarian Cancer: Validation of Future Biomarkers and Target of Therapy. (2026/07/22) ♡
- Implementing a perioperative weight management program for ovarian cancer patients undergoing ultra-radical cytoreduction: a quality improvement initiative. (2026/07/22) ♡
- Surgical axillary intervention after neoadjuvant systemic therapy (NST) for early-stage breast cancer - Clinical significance of micrometastases: Data from five neoadjuvant studies. (2026/07/22) ♡
- Long non-coding RNA LOC101926915-encoded micropeptide carboplatin-induced upregulation factor confers carboplatin resistance in ovarian cancer. (2026/07/21) ♡
- LOX-1 mediated lipid peroxidation leads to dysfunction of tumor infiltrating CD8(+) T cells in ovarian cancer. (2026/07/20) ♡
- Functional Data Analysis of Spatial Clustering Identifies Prognostic T Cell Patterns in Ovarian Cancer. (2026/07/20) ♡
- Association between HER2 expression, genomic characteristics, and tumor immune microenvironment dynamics in epithelial ovarian cancer. (2026/07/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Functional interplay between TTP/ZFP36 and HuR/ELAVL1 in cancer: a post-transcriptional regulatory network. (2026/07/20) ♡
- CTPS1 is an unexplored vulnerability in breast and ovarian cancer. (2026/07/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. EndoBridge 2025: pearls and highlights. (2026/07/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary ovarian synovial sarcoma in an adolescent mimicking a germ cell tumor: A case report and diagnostic challenge. (2026/07/19) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Milk of magnesia in enhanced recovery after surgery for preventing postoperative ileus after hysterectomy: randomized controlled trial. (2026/07/18) ♡
- Minimally invasive lateral pelvic sidewall resection for nodal recurrence of high-grade endometrioid endometrial carcinoma. (2026/07/18) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Causal assessment of 187 dietary habits with ovarian cancer from multiple sources via Mendelian randomization and meta-analysis. (2026/07/17) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.